Impact of tumor invasion on seminal vesicles mobility in radiotherapy of T3b prostate cancer

被引:0
|
作者
Buijs, M. [1 ]
Bergsma, L. [1 ]
De Vries, J. [2 ]
Kalisvaart, R. [1 ]
Pos, F. [1 ]
Heemsbergen, W. [1 ]
Remeijer, P. [1 ]
Van der Heide, U. A. [1 ]
机构
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Radiotherapy, Amsterdam, Netherlands
[2] Acad Med Ctr, Radiotherapy, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OC-0078
引用
收藏
页码:S39 / S40
页数:2
相关论文
共 50 条
  • [31] Analysis of renal cell carcinoma with subdiaphragmatic macroscopic venous invasion (T3b)
    Klaver, Sjoerd
    Joniau, Steven
    Suy, Raphael
    Oyen, Raymond
    Van Poppel, Hein
    BJU INTERNATIONAL, 2008, 101 (04) : 444 - 449
  • [32] Surgery for pathological T3a, T3b and lymph node positive, prostate cancer: surgical, functional and oncological outcomes
    Gilliland, Niall
    Vennam, Sarath
    Geraghty, Robert
    Peacock, Julian
    Crockett, Matthew
    Kearley, Samantha
    Oxley, Jon
    Porter, Tim
    Waine, Elizabeth
    Aning, Jonathan
    Rowe, Edward
    Koupparis, Anthony
    JOURNAL OF CLINICAL UROLOGY, 2022, 15 (01) : 25 - 35
  • [33] Treatment of prostate cancer with radiotherapy: Should the entire seminal vesicles be included in the clinical target volume?
    Kestin, LL
    Goldstein, NS
    Vicini, FA
    Yan, D
    Korman, HJ
    Martinez, AA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (03): : 686 - 697
  • [34] Radical prostatectomy for very high risk T3b/4 prostate cancer - results of a multiinstitutional experience
    Spahn, M.
    Gontero, P.
    Briganti, A.
    Kneitz, B.
    Bader, P.
    Hsu, C. Y.
    Van Poppel, H.
    Frohneberg, D.
    Joniau, S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E355 - E355
  • [35] Radiotherapy for T3 prostate cancer
    Andrew Bayley
    Mary K. Gospodarowicz
    Current Urology Reports, 2003, 4 (3) : 205 - 210
  • [36] Patterns of treatment failure in patients with prostate cancer treated with 76–80 Gy radiotherapy to the prostate and seminal vesicles ± hormonotherapy
    J. López-Torrecilla
    J. Pastor-Peidro
    A. Vicedo-González
    D. González-Sanchis
    A. Hernandez-Machancoses
    P. Almendros-Blanco
    E. García-Miragall
    J. C. Gordo-Partearroyo
    T. García-Hernández
    L. Brualla-González
    D. Granero-Cabañero
    J. Rosello-Ferrando
    Clinical and Translational Oncology, 2021, 23 : 481 - 490
  • [37] Biochemical Control after HDR Prostate Brachytherapy Boost for T3b Cancer: the Stokes Centre for Urology Experience
    Metawe, M.
    Uribe-Lewis, S.
    Otter, S.
    Mikropoulos, C.
    Perna, C.
    Langley, S.
    CLINICAL ONCOLOGY, 2024, 36 (01) : E82 - E82
  • [39] Patterns of treatment failure in patients with prostate cancer treated with 76-80 Gy radiotherapy to the prostate and seminal vesicles ± hormonotherapy
    Lopez-Torrecilla, J.
    Pastor-Peidro, J.
    Vicedo-Gonzalez, A.
    Gonzalez-Sanchis, D.
    Hernandez-Machancoses, A.
    Almendros-Blanco, P.
    Garcia-Miragall, E.
    Gordo-Partearroyo, J. C.
    Garcia-Hernandez, T.
    Brualla-Gonzalez, L.
    Granero-Cabanero, D.
    Rosello-Ferrando, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (03): : 481 - 490
  • [40] When to Biopsy the Seminal Vesicles: A Validated Multiparametric Magnetic Resonance Imaging and Target Driven Model to Detect Seminal Vesicle Invasion of Prostate Cancer
    Gold, Samuel A.
    Shih, Joanna H.
    Rais-Bahrami, Soroush
    Bloom, Jonathan B.
    Vourganti, Srinivas
    Singla, Nirmish
    Baroni, Ronaldo H.
    Coker, Michael A.
    Fialkoff, Jared
    Noschang, Julia
    Roehrborn, Claus G.
    Turkbey, Baris
    Pinto, Peter A.
    JOURNAL OF UROLOGY, 2019, 201 (05): : 943 - 949